ABVC BIOPHARMA, INC. Quarterly Interest Expense in USD from Q2 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Abvc Biopharma, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2010 to Q1 2024.
  • Abvc Biopharma, Inc. Interest Expense for the quarter ending March 31, 2024 was $685K, a 1108% increase year-over-year.
  • Abvc Biopharma, Inc. Interest Expense for the twelve months ending March 31, 2024 was $3.12M, a 839% increase year-over-year.
  • Abvc Biopharma, Inc. annual Interest Expense for 2023 was $2.49M, a 748% increase from 2022.
  • Abvc Biopharma, Inc. annual Interest Expense for 2022 was $294K, a 29.4% increase from 2021.
  • Abvc Biopharma, Inc. annual Interest Expense for 2021 was $227K, a 43.9% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $3.12M $685K +$628K +1108% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-17
Q4 2023 $2.49M $1.1M +$969K +721% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $1.52M $1.22M +$1.09M +863% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-15
Q2 2023 $432K $115K +$100K +678% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $332K $56.7K +$38.5K +211% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-17
Q4 2022 $294K $134K +$159K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $135K $127K +$87.9K +227% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-15
Q2 2022 $47.3K $14.8K -$67.9K -82.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $115K $18.2K -$112K -86% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $227K -$24.4K -$141K -121% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $368K $38.7K +$22.4K +137% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $346K $82.7K -$57.9K -41.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $404K $130K -$1.29K -0.98% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $405K $117K +$9.21K +8.57% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $396K $16.3K -$95.7K -85.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $491K $141K +$7.84K +5.91% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $484K $132K +$1.63K +1.26% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $482K $107K -$9.3K -7.96% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 $491K $112K -$10.4K -8.47% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-17
Q2 2019 $502K $133K +$15.9K +13.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $486K $130K +$23K +21.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-30
Q4 2018 $463K $117K +$88.3K +310% Oct 1, 2018 Dec 31, 2018 10-K 2020-05-15
Q3 2018 $374K $122K +$94.9K +345% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-18
Q2 2018 $280K $117K +$88.3K +310% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $191K $107K +$87.9K +462% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-28
Q4 2017 $103K $28.5K Oct 1, 2017 Dec 31, 2017 10-KT 2018-04-13
Q3 2017 $27.5K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $28.5K +$24.7K +659% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-20
Q1 2017 $19K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q2 2016 $3.75K +$3.75K Apr 1, 2016 Jun 30, 2016 10-Q/A 2018-03-19
Q3 2015 $0 $0 $0 Jul 1, 2015 Sep 30, 2015 10-K 2015-11-27
Q2 2015 $0 $0 $0 Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-19
Q1 2015 $0 $0 $0 Jan 1, 2015 Mar 31, 2015 10-Q/A 2015-06-05
Q4 2014 $0 $0 $0 Oct 1, 2014 Dec 31, 2014 10-Q 2015-04-17
Q3 2014 $0 $0 $0 Jul 1, 2014 Sep 18, 2014 10-K 2015-11-27
Q2 2014 $0 $0 -$16.5K -100% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-19
Q1 2014 $16.5K $0 -$16.2K -100% Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-06-05
Q4 2013 $32.7K $0 -$16.4K -100% Oct 1, 2013 Dec 31, 2013 10-Q 2015-04-17
Q3 2013 $49.1K $0 -$14.9K -100% Jul 1, 2013 Sep 30, 2013 10-K 2015-04-16
Q2 2013 $64K $16.5K +$3.04K +22.5% Apr 1, 2013 Jun 30, 2013 10-Q 2015-04-17
Q1 2013 $61K $16.2K +$3.9K +31.7% Jan 1, 2013 Mar 31, 2013 10-Q 2015-04-17
Q4 2012 $57.1K $16.4K -$30.6K -65.1% Oct 1, 2012 Dec 31, 2012 10-Q 2015-04-17
Q3 2012 $87.7K $14.9K -$265K -94.7% Jul 1, 2012 Sep 30, 2012 10-K 2015-04-16
Q2 2012 $353K $13.5K -$29.1K -68.3% Apr 1, 2012 Jun 30, 2012 10-Q 2015-04-16
Q1 2012 $382K $12.3K +$73.7K Jan 1, 2012 Mar 31, 2012 10-Q 2015-04-16
Q4 2011 $308K $47K +$103K Oct 1, 2011 Dec 31, 2011 10-Q 2015-04-16
Q3 2011 $205K $280K Jul 1, 2011 Sep 30, 2011 10-K 2015-04-15
Q2 2011 $42.6K +$105K Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-08-20
Q1 2011 -$61.4K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q4 2010 -$56.5K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-21
Q2 2010 -$62K Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.